XML 36 R26.htm IDEA: XBRL DOCUMENT
v3.23.1

Business Segments (Tables) | 9 Months Ended
--- | ---
Mar. 31, 2023
Business Segments |
Schedule of information regarding reportable segments | ​
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
​ |  | Three Months |  | Nine Months
For the Periods Ended March 31 |  | 2023 |  | 2022 |  | 2023 |  | 2022
Net sales |  |  |  |  |  |  |  |  |  |  |  |
Animal Health | ​ | $ | 164,434 | ​ | $ | 148,589 | ​ | $ | 483,096 | ​ | $ | 440,520
Mineral Nutrition | ​ |  | 62,922 | ​ |  | 69,033 | ​ |  | 184,212 | ​ |  | 190,120
Performance Products | ​ |  | 18,317 | ​ |  | 21,997 | ​ |  | 55,532 | ​ |  | 56,356
Total segments | ​ | $ | 245,673 | ​ | $ | 239,619 | ​ | $ | 722,840 | ​ | $ | 686,996
​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Depreciation and amortization | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 6,888 | ​ | $ | 6,935 | ​ | $ | 20,733 | ​ | $ | 19,872
Mineral Nutrition | ​ |  | 671 | ​ |  | 661 | ​ |  | 1,985 | ​ |  | 1,960
Performance Products | ​ |  | 453 | ​ |  | 436 | ​ |  | 1,348 | ​ |  | 1,292
Total segments | ​ | $ | 8,012 | ​ | $ | 8,032 | ​ | $ | 24,066 | ​ | $ | 23,124
Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Animal Health | ​ | $ | 34,217 | ​ | $ | 29,232 | ​ | $ | 98,240 | ​ | $ | 90,565
Mineral Nutrition | ​ |  | 3,859 | ​ |  | 7,303 | ​ |  | 13,555 | ​ |  | 17,361
Performance Products | ​ |  | 2,413 | ​ |  | 2,865 | ​ |  | 7,069 | ​ |  | 6,327
Total segments | ​ | $ | 40,489 | ​ | $ | 39,400 | ​ | $ | 118,864 | ​ | $ | 114,253
Reconciliation of income before income taxes to Adjusted EBITDA | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​ | ​
Income before income taxes | ​ | $ | 15,104 | ​ | $ | 26,833 | ​ | $ | 32,630 | ​ | $ | 59,958
Interest expense, net | ​ |  | 3,871 | ​ |  | 2,925 | ​ |  | 10,822 | ​ |  | 8,767
Depreciation and amortization – Total segments | ​ |  | 8,012 | ​ |  | 8,032 | ​ |  | 24,066 | ​ |  | 23,124
Depreciation and amortization – Corporate | ​ |  | 477 | ​ |  | 413 | ​ |  | 1,372 | ​ |  | 1,176
Corporate costs | ​ | ​ | 13,122 | ​ | ​ | 11,404 | ​ | ​ | 38,451 | ​ | ​ | 34,699
Environmental remediation costs | ​ | ​ | 325 | ​ | ​ | — | ​ | ​ | 6,894 | ​ | ​ | —
Gain on sale of investment | ​ | ​ | — | ​ | ​ | — | ​ | ​ | — | ​ | ​ | (1,203)
Acquisition-related cost of goods sold | ​ |  | — | ​ |  | 78 | ​ |  | — | ​ |  | 78
Acquisition-related transaction costs | ​ |  | — | ​ |  | 279 | ​ |  | — | ​ |  | 279
Foreign currency (gains) losses, net | ​ |  | (422) | ​ |  | (10,564) | ​ |  | 4,629 | ​ |  | (12,625)
Adjusted EBITDA – Total segments | ​ | $ | 40,489 | ​ | $ | 39,400 | ​ | $ | 118,864 | ​ | $ | 114,253
Schedule of identifiable assets | ​
​ | ​ | ​ | ​ | ​ | ​ | ​
​ | ​ | March 31, |  | June 30,
As of |  | 2023 |  | 2022
Identifiable assets |  | ​ |  |  | ​ |
Animal Health | ​ | $ | 686,510 | ​ | $ | 654,862
Mineral Nutrition | ​ |  | 91,205 | ​ |  | 87,379
Performance Products | ​ |  | 47,522 | ​ |  | 39,490
Total segments | ​ |  | 825,237 | ​ |  | 781,731
Corporate | ​ |  | 140,195 | ​ |  | 149,968
Total | ​ | $ | 965,432 | ​ | $ | 931,699

X
- Definition Tabular disclosure of all significant reconciling items in the reconciliation of total assets from reportable segments to the entity's consolidated assets. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -Subparagraph (c) -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 31 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8924-108599 + Details
Name: | us-gaap_ReconciliationOfAssetsFromSegmentToConsolidatedTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- Definition Tabular disclosure of the profit or loss and total assets for each reportable segment. An entity discloses certain information on each reportable segment if the amounts (a) are included in the measure of segment profit or loss reviewed by the chief operating decision maker or (b) are otherwise regularly provided to the chief operating decision maker, even if not included in that measure of segment profit or loss. + References Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 22 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8736-108599 Reference 2: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 25 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8813-108599 Reference 3: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 350 -SubTopic 20 -Section 50 -Paragraph 1 -URI https://asc.fasb.org/extlink&oid=121556970&loc=d3e13816-109267 Reference 4: http://fasb.org/us-gaap/role/ref/legacyRef -Publisher FASB -Name Accounting Standards Codification -Topic 280 -SubTopic 10 -Section 50 -Paragraph 30 -URI https://asc.fasb.org/extlink&oid=126901519&loc=d3e8906-108599 + Details
Name: | us-gaap_ScheduleOfSegmentReportingInformationBySegmentTextBlock
Namespace Prefix: | us-gaap_
Data Type: | dtr-types:textBlockItemType
Balance Type: | na
Period Type: | duration

X
- References No definition available. + Details
Name: | us-gaap_SegmentReportingAbstract
Namespace Prefix: | us-gaap_
Data Type: | xbrli:stringItemType
Balance Type: | na
Period Type: | duration